Anti-reabsorptive agents in women with osteoporosis: Determining statistical equivalence according to evidence-based methods

Journal of Endocrinological Investigation

Volumn 37, Issue 8, 2014, Pages 769-773

  Messori, Andrea ^a   Fadda, Valeria ^a   Maratea, Dario ^a   Trippoli, Sabrina ^a   Marinai, Claudio ^b  

^a HTA Unit Area Vasta Centro Toscana Regional Health System   (Italy)

^b ESTAV Toscana Centro   (Italy)

Author keywords

Alendronate; Denosumab; Equivalence; Ibandronate; Meta analysis; Osteoporosis; Risedronate

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; IBANDRONIC ACID; PLACEBO; RISEDRONIC ACID; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; ETIDRONIC ACID; MONOCLONAL ANTIBODY;

ARTICLE; EVIDENCE BASED PRACTICE; HUMAN; META ANALYSIS; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SPINE FRACTURE; THERAPEUTIC EQUIVALENCE; ANALOGS AND DERIVATIVES; EVIDENCE BASED MEDICINE; FEMALE; INCIDENCE; METABOLISM; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PATHOPHYSIOLOGY; SPINAL FRACTURES;

ALENDRONATE; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; ETIDRONIC ACID; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INCIDENCE; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL FRACTURES; THERAPEUTIC EQUIVALENCY;

EID: 84907369633     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0124-3     Document Type: Article

References (10)

1. Ahn S, Park SH, Lee KH (2013) How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research. Radiology 267(2):328-338
2. Messori A, Fadda V, Maratea D, Trippoli S (2014) The Italian way to evidence-based demonstration of equivalence as a pre-requisite for conducting procurement tendering within the NHS (Rapid Response), thebmj. http://www.bmj.com/content/347/bmj.f4951/rr/759376. Accessed 1 July 2014
3. Migliore A, Broccoli S, Massafra U, Cassol M, Frediani B (2013) Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis. Eur Rev Med Pharmacol Sci 17(5):658-667
4. Norman G, Monteiro S, Salama S (2012) Sample size calculations: should the emperor's clothes be off the peg or made to measure? BMJ 23(345):e5278. doi:10.1136/bmj.e5278
5. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA (2014) Minimal clinically important differences in pharmacological trials. Am J Respir Crit CareMed 189(3):250-255
6. Fadda V, Maratea D, Trippoli S, Messori A (2011) Network meta-analysis. Results can be summarised in a simple figure. BMJ 23(342):d1555
7. Messori A (2014) Comment, PubMed Commons. Available at http://www.ncbi.nlm.nih.gov/pubmed/23543450/#comments. Accessed 5 Apr 2014
8. Arruda MA (2013) No evidence of efficacy or evidence of no efficacy. JAMA Pediatr 167(3):300-302
9. Messori A, Fadda V, Maratea D, Trippoli S (2013) Erythropoiesis- stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness? Eur J Heart Fail 15(8):944-945
10. Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C (2013) Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int 24(1):209-217